|
|
Post by mnkdfann on Jun 28, 2019 20:57:42 GMT -5
What does 10% of the shares outstanding entitle them to do legally, that they could not do before? I mean, does it entitle them to appoint a Director to the Board or something? Or the rights to view certain corporate documents? And will they vet these anonymous share commitments, or are the 5,000,000 shares of Buzz Lichtjhar still being included in the count?  |
|
|
|
Post by mnkdfann on Jun 25, 2019 19:33:38 GMT -5
nylefty - it's a little low ... but, if you use your right hand and click that volume button four or five times ... then it isn't too bad. Seems that they are using the video camera mic and it's far away. Also slight echo echo echo. And I totally don't hear Bill.But, that's mytakeonit I read those lines you wrote, and I wonder whether you are actually turning the volume down? Or up, but it's okay because you still don't hear Bill? |
|
|
|
Post by mnkdfann on Jun 25, 2019 10:17:59 GMT -5
MNKD share price up 4.5% this morning!
|
|
|
|
Post by mnkdfann on Jun 25, 2019 8:54:33 GMT -5
It is often said 50% of something is better than all of nothing. I agree it would be ideal to go it alone, but that hasn't worked so far and MNKD isn't showing any signs of increasing shareholder value to date. Okay, . . . how does the revenue in Afrezza sales for adults in the USA over the last two years looks like? It quadrupled and there is no slowing down! About 4.5mil$ for June19, from less than 1mil$ Jan 2017
Show me any company with similar numbers!
Only since you asked nicely ... Keytruda: 2018: $7.171 billion 2017: $3.809 billion 2016: $1.4 billion 2015: $566 million. But I'll grant you Afrezza's revenue grew faster (%-wise) than Humira's over the last the last year. Humira: 2018 Sales: $19.936 billion 2017 Sales: $18.427 billion % Change: 8.2% Look up 'flop' in Websters and you'll find a picture of Humira. |
|
|
|
Post by mnkdfann on Jun 24, 2019 22:03:55 GMT -5
I wonder which way vdexdiabetes voted.  |
|
|
|
Polls
Jun 24, 2019 20:20:25 GMT -5
Post by mnkdfann on Jun 24, 2019 20:20:25 GMT -5
Those of you that have been around a while know that I am not a big fan of the "poll" feature on this board. Let's not get carried away on polling every little thing or I will turn it off. Any polls created without an expiration, or with an expiration > 1 week will be disabled. Have you considered a forum for polls and only polls, and barred them everywhere else, so that they do not 'clutter' up every other forum? |
|
|
|
Post by mnkdfann on Jun 24, 2019 19:39:41 GMT -5
If I were CEO, I would work without paycheck.....until I returned value to shareholders. How much did Mike make before he became CEO of MNKD? There is no difference between Mike Castagna and all of the politicians getting earning a living they would never have without the government job. So people with great responsibility should work for free? Like it's not hard enough already to recruit talented people for those positions. |
|
|
|
Post by mnkdfann on Jun 24, 2019 18:25:39 GMT -5
IMO, there is a long way to go until that would become a serious issue. I mean, there are a number of events / opportunities between then and now.
"If a company trades for 30 consecutive business days below the $1.00 minimum closing bid price requirement, Nasdaq will send a deficiency notice to the company, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements."
|
|
|
|
Post by mnkdfann on Jun 24, 2019 16:31:41 GMT -5
I'm not quite sure what is old or new content on that site (so this next may be old), but there is a Mannkind mention here under Wesner's entry: www.receptorlife.com/leadership |
|
|
|
Post by mnkdfann on Jun 24, 2019 15:12:57 GMT -5
I beleive it was mentione on the JP cc re 2nd uthr molecule. Great !!! I hadn't listened to that. Of course now the Eeyore in me is thinking... shoot, that means it's already baked into the share price. I'm guessing that the deal doesn't stipulate disclosure of the API when they option it, so likely we won't find out until details of the first clinical trial are made public. The slides say: "Research Agreement for undisclosed PAH compound - Formulation work ongoing and anticipate a decision in 2H" In the call, he said they will "announce sometime in Q3 what we intend to do with that". I read this all as there could be a payment in 2H or later, IF the formulation goes okay etc. |
|
|
|
Post by mnkdfann on Jun 24, 2019 14:02:49 GMT -5
Vdex, "Affecting Blood Pressure" as well. |
|
|
|
Post by mnkdfann on Jun 24, 2019 13:33:26 GMT -5
Mike trash talked Matt, and now Bill is trash talking Mike. In the first case it was awful, but in the second case it's OK?
As for needing activists and changing Mannkind management, I look at where we were in Jan 2017, and I look at where we are now. Some might want to say that any success since then was because of Matt, but that's not believable, just as saying all success since then is because of Mike. I think THE TRUTH is that it's damnably hard (and/or expensive) to be successful selling Afrezza, and there is no magic, there is no silver bullet.
Mike wasn't on the scene when the black box label was applied. Mike wasn't on the scene when Sanofi backstabbed. Folks say Matt P did a great job of getting $50M cash and debt forgiven. I think an activist getting shareholders (not MNKD) to sue Sanofi might have been more successful. Don't know, but $750M in unpaid milestones, and complete sandbagging (and denegrating) Afrezza might easily have been worth more than what Matt P got. I'm not judging because I wasn't there to listen to the lawyers and negotiate the divorce, but I'm also not going to glibly agree that Matt P did the best that was possible.
I think Matt P was a good CFO but when Mike got promoted I was glad for the change, and I've been happy with the results. Apparently the Board of Directors and the major stockholders agree with my sentiments because THEY are the ones who made that change, and THEY are the ones that agreed to the raises, bonuses, and stock options.
The "December massacre" is a red herring and a farce. Look at the charts for 4Q 2018 and tell me how any CEO would know that the market would stop it's downward trend in 2019?
So to me, what I see is a trash-talking businessman with an agenda for a business proposal that doesn't look particularly good. If VDEX was going gangbusters, maybe, but 25 scripts a MONTH from 2 clinics (or if it is 6 clinics - that's even worse). And an equal number or prescriptions given away? Even if there was some hyperbole in those numbers, come on, who are we kidding? There is little value at best and negative value in that business model. Retention? I'm supposed to believe that all of the other Afrezza prescriptions that are being written and all of the diabetes educators, endos, and Primary Care physicians, and most importantly, Persons With Diabetes, cannot possible do what VDEX has done? Only VDEX knows the dark arcane secrets behind successfully titrating Afrezza? Only VDEX can lead us to profitability?
I cannot imagine what could persuade me a trash-talking video-making CEO of a tiny clinic company that we don't know is profitable and don't know who are the investors that established it, or the ones who are promising boatloads of money if they can get Mannkind to agree to a deal which is grossly favorable to them, and with an agenda to materially change the management of the company whose shares I can and do own, and who has already been eroding goodwill and destroying investor faith, is the savior of the value of my shares.
If Mike trash talked Matt, then what Bill said is just revealing the truth. Vdex is a customer of Mannkind. They offered to help promoting Afrezza. If Mike believes the deal is not good for Mannkind, he should list the reasons, not just dismissed them with the claim that Vdex had less than 25 scripts per month. How many clinics prescribed more than 25 scripts per month anyway? Mike did. He gave a list including 5 different reasons, that went considerably beyond just the <25 scripts thing. The reasons may not satisfy you, but he gave several. |
|
|
|
Post by mnkdfann on Jun 24, 2019 13:26:57 GMT -5
I think Matt P was a good CFO but when Mike got promoted I was glad for the change, and I've been happy with the results. Apparently the Board of Directors and the major stockholders agree with my sentiments because THEY are the ones who made that change, and THEY are the ones that agreed to the raises, bonuses, and stock options. I've been browsing old threads, and came across this one from when MC was appointed CEO. As a courtesy, I include the link below: mnkd.proboards.com/thread/7957/mannkind-provides-update-senior-managementI found it interesting and a couple of things said take on new meaning now, but YMMV. |
|
|
|
Post by mnkdfann on Jun 24, 2019 12:34:06 GMT -5
FIRST OFFER OF $3.00 TO BUY THE COMPANY WINS....... Unfortunately, I've been invested in companies before that were not market favourites and were bought out for a song, much less than what retail shareholders thought fair. One recent example: I was buying HBC (HBC.TO Hudson's Bay Co.) for a number of years, as it seemed undervalued. Its real estate portfolio is (according to many analysts) worth $9 billion or so (including some prime NYC real estate), but the share price has been dropping from $27+ and HBC's market cap a month ago was just a bit over $1 billion when the share price was $6 or so. Meanwhile, its Co Executive Chairman was buying shares all the way down. You'd think that was a good sign. Yet the Board never sought to (seriously) unload any of the real estate to capture this value. Now the Co Executive Chairman has made a buyout / privatisation offer that values the company at $2 billion or so. Buyout at $9.45. Do the math. Shareholders are getting hosed, but the CEC and his affiliates will make out like bandits. Should have seen this coming, I suppose. If Mannkind is bought out some people might do very well indeed, but it won't be the retail shareholder IMO. If there is a buyout, I think we would be lucky to see anything over $2. |
|
|
|
Post by mnkdfann on Jun 24, 2019 11:15:29 GMT -5
Absolutely not correct. I just did a test with a really old post of mine. No problem deleting it. The rules say you can't do it, but a moderator can do it for you. Post by BD on Aug 27, 2013 at 8:10pm
I've noticed that some members are having difficulty with quoting/replying, so multiple posts (or quoted contents of previous posts without any reply) are getting posted.
Please note that you have several tools at your disposal:
1) you can preview your post using the "Preview" button at the bottom of the composition area
2) AFTER you've posted, you can go back and either edit or completely delete your post for up to 60 minutes. So if there's a duplicate, please just go in and delete the extraneous copy yourselves. As a mod, I'm reluctant to go in and do it because of the possibility that a member is, at exactly the same time, deleting the other one, leaving no copies of the post at all. With my luck, that's what would happen, lol.
Perhaps there is a bug in the system, so that some have this ability and others do not, but I just tried and (apparently) like uvula I was able to delete and edit my own posts from months ago. Perhaps I have secret mod powers? |
|
